Skip to main content
logo
Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
14.89
+0.06 (0.40%)
At close: Oct 21, 2026, 4:00 PM EDT
14.70
-0.19 (-1.28%)
Pre-market: Oct 22, 2026, 8:30 AM EDT

Cullinan Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-204.69-219.88-167.38-153.16111.21-65.57
Depreciation & Amortization
0.320.310.310.310.090.05
Loss (Gain) From Sale of Assets
-----276.86-
Asset Writedown & Restructuring Costs
---0.44--
Loss (Gain) From Sale of Investments
-3.62-6.31-15.47-10.151.43.1
Stock-Based Compensation
32.8436.0437.8230.4427.9624.38
Other Operating Activities
---0.19-1.94-2.02-1.85
Change in Accounts Payable
1.27-0.84-0.81-0.17-0.51-4.84
Change in Income Taxes
----4.284.28-
Change in Other Net Operating Assets
14.6414.920.424.117.41.29
Operating Cash Flow
-159.25-175.75-145.3-134.28-126.66-43.43
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.05-0.05--0.21-1.13-
Sale of Property, Plant & Equipment
----0.09-
Divestitures
----275-
Investment in Securities
162.92180.04-136.3136.01-24.98-333.78
Investing Cash Flow
162.88179.99-136.3135.81248.98-333.78

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---1.832.38-
Total Debt Issued
---1.832.38-
Short-Term Debt Repaid
-----2.2-
Total Debt Repaid
-----2.2-
Net Debt Issued (Repaid)
---1.830.18-
Issuance of Common Stock
2.21.09270.6438.936.02270.55
Other Financing Activities
---4.45--32.13-1.77
Financing Cash Flow
2.21.09266.1940.75-25.93268.78

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
5.825.33-15.43-57.7296.38-108.42

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-159.3-175.8-145.3-134.48-127.8-43.43
Free Cash Flow Growth
------
Free Cash Flow Margin
------229.28%
Free Cash Flow Per Share
-2.65-2.98-2.70-3.24-2.74-1.01
Levered Free Cash Flow
-89.23-100.28-84.86-88.76-47.6-24.64
Unlevered Free Cash Flow
-89.23-100.28-84.86-88.76-47.6-24.64

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
--2.97-2.27-4.4337.8-
Change in Working Capital
15.914.08-0.39-0.3411.18-3.54
SEC Filings: 10-K · 10-Q